Verisante Technology Inc. (VRSEF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 47.1 Thousand CAD | -49.44% |
| 2022 | 93.16 Thousand CAD | -94.54% |
| 2021 | 1.7 Million CAD | 23.63% |
| 2020 | 1.37 Million CAD | 3.34% |
| 2019 | 1.33 Million CAD | -16.5% |
| 2018 | 1.59 Million CAD | -42.92% |
| 2017 | 2.8 Million CAD | 8.54% |
| 2016 | 2.58 Million CAD | 23.53% |
| 2015 | 2.08 Million CAD | 34.63% |
| 2014 | 1.55 Million CAD | 126.06% |
| 2013 | 686.36 Thousand CAD | -13.52% |
| 2012 | 793.67 Thousand CAD | 15.46% |
| 2011 | 687.39 Thousand CAD | 336.53% |
| 2010 | 157.46 Thousand CAD | 76.02% |
| 2009 | 89.46 Thousand CAD | 126.2% |
| 2008 | 39.54 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 30.63 Thousand CAD | 20.8% |
| 2024 Q1 | 25.35 Thousand CAD | -46.16% |
| 2023 Q4 | 47.1 Thousand CAD | 162.29% |
| 2023 Q1 | 110.2 Thousand CAD | 18.29% |
| 2023 Q3 | 17.95 Thousand CAD | -84.61% |
| 2023 FY | 47.1 Thousand CAD | -49.44% |
| 2023 Q2 | 116.65 Thousand CAD | 5.86% |
| 2022 Q2 | 1.7 Million CAD | 3.79% |
| 2022 Q1 | 1.64 Million CAD | -3.76% |
| 2022 Q3 | 1.73 Million CAD | 2.1% |
| 2022 FY | 93.16 Thousand CAD | -94.54% |
| 2022 Q4 | 93.16 Thousand CAD | -94.64% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 FY | 1.7 Million CAD | 23.63% |
| 2021 Q4 | 1.7 Million CAD | 0.0% |
| 2020 FY | 1.37 Million CAD | 3.34% |
| 2019 FY | 1.33 Million CAD | -16.5% |
| 2018 FY | 1.59 Million CAD | -42.92% |
| 2017 Q4 | 2.8 Million CAD | -5.08% |
| 2017 Q1 | 2.76 Million CAD | 7.17% |
| 2017 Q2 | 2.85 Million CAD | 3.16% |
| 2017 FY | 2.8 Million CAD | 8.54% |
| 2017 Q3 | 2.95 Million CAD | 3.44% |
| 2016 Q1 | 2.25 Million CAD | 7.97% |
| 2016 Q4 | 2.58 Million CAD | 3.29% |
| 2016 Q3 | 2.49 Million CAD | 3.01% |
| 2016 Q2 | 2.42 Million CAD | 7.53% |
| 2016 FY | 2.58 Million CAD | 23.53% |
| 2015 FY | 2.08 Million CAD | 34.63% |
| 2015 Q1 | 1.58 Million CAD | 2.11% |
| 2015 Q2 | 1.68 Million CAD | 6.59% |
| 2015 Q3 | 1.82 Million CAD | 8.03% |
| 2015 Q4 | 2.08 Million CAD | 14.51% |
| 2014 Q1 | 888.86 Thousand CAD | 29.5% |
| 2014 FY | 1.55 Million CAD | 126.06% |
| 2014 Q3 | 1.4 Million CAD | 13.49% |
| 2014 Q4 | 1.55 Million CAD | 10.08% |
| 2014 Q2 | 1.24 Million CAD | 39.73% |
| 2013 Q3 | 493.67 Thousand CAD | 62.99% |
| 2013 FY | 686.36 Thousand CAD | -13.52% |
| 2013 Q4 | 686.36 Thousand CAD | 39.03% |
| 2013 Q2 | 302.89 Thousand CAD | -41.3% |
| 2013 Q1 | 515.98 Thousand CAD | -34.99% |
| 2012 Q4 | 793.67 Thousand CAD | 251.23% |
| 2012 FY | 793.67 Thousand CAD | 15.46% |
| 2012 Q1 | 215.41 Thousand CAD | -68.66% |
| 2012 Q2 | 201.03 Thousand CAD | -6.68% |
| 2012 Q3 | 225.97 Thousand CAD | 12.41% |
| 2011 FY | 687.39 Thousand CAD | 336.53% |
| 2011 Q1 | 146.93 Thousand CAD | -6.69% |
| 2011 Q2 | 157.16 Thousand CAD | 6.96% |
| 2011 Q3 | 218.83 Thousand CAD | 39.23% |
| 2011 Q4 | 687.39 Thousand CAD | 214.12% |
| 2010 Q1 | 133.97 Thousand CAD | 49.76% |
| 2010 FY | 157.46 Thousand CAD | 76.02% |
| 2010 Q4 | 157.46 Thousand CAD | 46.58% |
| 2010 Q3 | 107.42 Thousand CAD | 9.93% |
| 2010 Q2 | 97.72 Thousand CAD | -27.06% |
| 2009 Q4 | 89.46 Thousand CAD | -67.21% |
| 2009 Q3 | 272.86 Thousand CAD | 0.0% |
| 2009 FY | 89.46 Thousand CAD | 126.2% |
| 2008 FY | 39.54 Thousand CAD | 0.0% |
| 2008 Q4 | 39.54 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | 2.11 Million USD | 97.776% |
| Össur hf. | 688.8 Million USD | 99.993% |
| QHSLab, Inc. | 2.05 Million USD | 97.71% |
| Wellstar International, Inc. | 55.99 Million USD | 99.916% |
| Össur hf. | 688.8 Million USD | 99.993% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 2.94 Million USD | 98.402% |
| Aurora Spine Corporation | 6.65 Million USD | 99.292% |
| BrainsWay Ltd. | 15.31 Million USD | 99.692% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| AVITA Medical, Inc. | 19.86 Million USD | 99.763% |
| CVR Medical Corp. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 99.897% |
| BioElectronics Corporation | 16.62 Million USD | 99.717% |
| Vivos Inc. | 245 Thousand USD | 80.775% |
| Kelyniam Global, Inc. | 1.01 Million USD | 95.35% |
| Zecotek Photonics Inc. | 5.86 Million USD | 99.197% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | 82.91% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 99.707% |
| Avitar, Inc. | 11.59 Million USD | 99.594% |
| Nanomix Corporation | 14.81 Million USD | 99.682% |
| Theraclion SA | 13.01 Million EUR | 99.638% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | 99.081% |
| NewCardio, Inc. | 6.01 Million USD | 99.217% |
| Positron Corporation | 2.02 Million USD | 97.675% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | 98.699% |
| Lombard Medical, Inc. | 53.79 Million USD | 99.912% |
| ALR Technologies Inc. | 24.5 Million USD | 99.808% |
| Stratec SE | 271.97 Million USD | 99.983% |
| Vycor Medical, Inc. | 4.31 Million USD | 98.909% |
| Heart Tronics, Inc. | 1.09 Million USD | 95.698% |
| Nu-Med Plus, Inc. | 2.35 Million USD | 98.003% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.998% |
| VMS Rehab Systems, Inc. | 201.36 USD | -23291.935% |
| Guided Therapeutics, Inc. | 5.47 Million USD | 99.14% |
| Ingen Technologies, Inc. | 5.7 Million USD | 99.175% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | 98.077% |
| Odyssey Group International, Inc. | 6.61 Million USD | 99.288% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 99.928% |
| IR-Med Inc. | 634 Thousand USD | 92.571% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 99.14% |
| United American Healthcare Corporation | 119 Thousand USD | 60.418% |
| Polarean Imaging plc | 2.58 Million USD | 98.175% |
| ECGI Holdings, Inc. | 11.94 Million USD | 99.606% |
| Capital Group Holdings, Inc. | 1.32 Million USD | 96.442% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | 96.743% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | 93.049% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 99.127% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 99.445% |
| SS Innovations International, Inc. | 11.18 Million USD | 99.579% |
| Urologix, Inc. | 12.64 Million USD | 99.627% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | 91.035% |
| Smith & Nephew plc | 4.76 Billion USD | 99.999% |
| NIOX Group Plc | 9.8 Million USD | 99.519% |
| Fuse Medical, Inc. | 15.11 Million USD | 99.688% |
| Broncus Holding Corporation | 10.43 Million USD | 99.548% |
| Brain Scientific Inc. | 7.42 Million USD | 99.366% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 99.861% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | 94.068% |